An Evaluation of Skin and Immunological Responses after Using a Novel Cross-Linked Porcine-Based Dermal Injectable Collagen with Lidocaine for Nasolabial Fold Correction
Journal of Clinical Medicine · 04.09.2024 · 13 (17) · 5241
DOI: 10.3390/jcm13175241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.09.2024. Verfasst von Hao-Chih Tai und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sunmax Biotechnology Ltd..
Abstract (Originalsprache)
Background
Hypersensitivity to the new dermal injectable porcine-based collagen with lidocaine featuring a novel cross-linking technology (test filler) for nasolabial fold correction was compared to the commercially available traditional cross-linked dermal injectable porcine-based collagen with lidocaine (control filler).
Methods
Recruited participants (n = 279) received a single 0.1 mL intradermal injection of either test filler or control filler in the left forearm as a screening skin allergy test. Injection sites were assessed clinically at 24 h post-implant. Treatment was given to 252 successfully screened participants, and injection sites were monitored for 21 days. Immunological examinations were performed at screening and then at 4 and 24 weeks post-treatment. Observations for adverse events continued until the 52nd week.
Results
Intradermal allergy testing results were negative for all the test recipients (0/124) and positive for two control recipients (2/132, 1.5%). Most of the participants exhibited no changes in serum immunoglobulin (IgG, IgM) and complement (C3, C4) levels. No serious adverse events related to the device were recorded. Most adverse events were common complications of dermal filler treatment and were related to the injection site. Most adverse effects were resolved or under control by 52 weeks.
Conclusions
Hypersensitivity reactions with the test filler were lower than those with the control filler, validating the safe use of test filler for nasolabial fold correction without the need for pretreatment skin testing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan.
- Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan.
- Department of Dermatology, Linkou Chang-Gung Memorial Hospital, Taoyuan 333, Taiwan.
- Department of Dermatology, New Taipei Municipal TuCheng Hospital, New Taipei City 236, Taiwan.
- Department of Dermatology, Chang-Gung Memorial Hospital, Keelung 204, Taiwan.
- Division of Plastic Surgery, Tri-Service General Hospital, Taipei 100, Taiwan.
ORCID-Profile: Ya-Ching Chang, Chin-Yi Yang, Yi-Shuan Sheen, Yuan-Sheng Tzeng, Chang-Yi Chou
Förderung
- Sunmax Biotechnology Ltd.
Zitieren
APA
Tai, H. C., Liao, Y. H., Chang, Y. C., Yang, C. Y., Horng, S. Y., Kuo, Y. S., Sheen, Y. S., Huang, Y. H., Hui, R. C., Chen, T. M., Tzeng, Y. S., Wang, C. H., Teng, S. C., Chang, C. O., & Chou, C. Y. (2024). An Evaluation of Skin and Immunological Responses after Using a Novel Cross-Linked Porcine-Based Dermal Injectable Collagen with Lidocaine for Nasolabial Fold Correction. Journal of Clinical Medicine, 13(17), 5241. https://doi.org/10.3390/jcm13175241
Vancouver
Tai HC, Liao YH, Chang YC, Yang CY, Horng SY, Kuo YS, et al. An Evaluation of Skin and Immunological Responses after Using a Novel Cross-Linked Porcine-Based Dermal Injectable Collagen with Lidocaine for Nasolabial Fold Correction. Journal of Clinical Medicine. 2024;13(17):5241. doi:10.3390/jcm13175241
BibTeX
@article{Tai2024,
author = {Tai, Hao-Chih and Liao, Yi-Hua and Chang, Ya-Ching and Yang, Chin-Yi and Horng, Shyue-Yih and Kuo, Yuan-Sung and Sheen, Yi-Shuan and Huang, Yu-Huei and Hui, Rosaline Chung-Yee and Chen, Tim-Mo and Tzeng, Yuan-Sheng and Wang, Chih-Hsin and Teng, Shou-Cheng and Chang, Chun-Kai Oscar and Chou, Chang-Yi},
title = {An Evaluation of Skin and Immunological Responses after Using a Novel Cross-Linked Porcine-Based Dermal Injectable Collagen with Lidocaine for Nasolabial Fold Correction},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {17},
pages = {5241},
doi = {10.3390/jcm13175241}
}
EUVIMED